Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Eur J Pediatr ; 181(3): 1259-1262, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34595613

ABSTRACT

Cytomegalovirus (CMV) is the most frequent cause of congenital infection all over the world. Its prevalence ranges from 0.2 to 2.2%. Transmission from children to their pregnant mothers is a well-known risk factor, particularly if they attend a childcare centre. This study aims to compare the prevalence of CMV congenital infection (CMV_CI) in Portugal (Lisbon) between two studies, performed respectively in 2019 and 2020. In the 2019 study, performed in two hospitals, we found a 0.67% CMV_CI prevalence, using a pool strategy previously tested with saliva samples. In the 2020 study, using the same pool approach in four hospitals (the previous and two additional), and based on 1277 samples, the prevalence was 0.078%.Conclusion: The close temporal coincidence with COVID-19 lockdown suggests that these measures may have had a significant impact on this reduction, although other explanations cannot be ruled-out. What is Known: • Cytomegalovirus is the leading cause of congenital infection. • Behavioural measures decrease cytomegalovirus seroconversion in pregnant women. What is New: • From 2019 to 2020 there was a significant reduction in the prevalence of congenital CMV infection.


Subject(s)
COVID-19 , Cytomegalovirus Infections , Pregnancy Complications, Infectious , COVID-19/epidemiology , COVID-19/prevention & control , Child , Communicable Disease Control , Cytomegalovirus Infections/congenital , Cytomegalovirus Infections/epidemiology , Cytomegalovirus Infections/prevention & control , Female , Humans , Portugal/epidemiology , Pregnancy , Pregnancy Complications, Infectious/epidemiology , Pregnancy Complications, Infectious/prevention & control , Prevalence , SARS-CoV-2
2.
Eur J Pediatr ; 180(4): 1067-1072, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33052471

ABSTRACT

Human cytomegalovirus (HCMV) is the leading congenital infection agent in the world. The importance of screening this infection has been debated, as 10-15% of the asymptomatic newborns with HCMV at birth will present late sequelae. The aim of this study was to test the feasibility of using saliva pools from newborns in a screening program for congenital HCMV infection, in two Portuguese hospitals. The screening was based on the use of pools of 10 saliva samples for detection of viral DNA by real-time PCR. Whenever there was a positive pool, the samples were tested individually, and for each positive sample the result was confirmed with a urine sample collected in the first 2 weeks of life. The study involved 1492 newborns. One hundred and fifty pools were screened, with 14 positive results in saliva, but only 10 were confirmed in urine samples, giving a prevalence of congenital HCMV infection in both hospitals of 0.67% (CI95% 0.36 to 1.23%).Conclusion: The overall prevalence of congenital HCMV infection in both hospitals was 0.67%. The use of saliva pools proved to be effective for the screening of this congenital infection, allowing timely screening and confirmation in a large population, with associated cost reduction. What is Known: • Newborn screening for HCMV is desirable. • Saliva is a good and practical sample. What is New: • The feasibility of using saliva pools for a large-scale screening. • The cost reduction of this strategy.


Subject(s)
Cytomegalovirus Infections , Cytomegalovirus , Cytomegalovirus/genetics , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/epidemiology , DNA, Viral , Female , Humans , Infant, Newborn , Neonatal Screening , Real-Time Polymerase Chain Reaction , Saliva
3.
BMJ Case Rep ; 12(11)2019 Nov 05.
Article in English | MEDLINE | ID: mdl-31694828

ABSTRACT

We present two clinical cases of lymphadenopathy after vaccination with the human papillomavirus (HPV) 9-valent vaccine: an asymptomatic 11-year-old boy with inferior cervical and supraclavicular lymphadenopathy, and a 13-year-old girl who presented with lymphadenopathy. In both cases, medical history was unremarkable and there was no recent infection, or other clinical findings. Both adolescents had received the HPV 9-valent vaccine in the previous week. In the first case, blood tests, ultrasonography and biopsy were performed, while in the second, a watchful waiting strategy was adopted. In both cases, the lymphadenopathy resolved spontaneously. The boy received the second dose of the vaccine 6 months later and lymphadenopathy reappeared. The Naranjo scale was applied, classifying the events as definite (in the case of the boy) and probable (girl) adverse drug reactions. The vaccine is safe, but recognising this minor adverse event is important to prevent unnecessary investigation and reduce patient and parental anxiety.


Subject(s)
Lymph Nodes/pathology , Lymphadenopathy/chemically induced , Papillomavirus Infections/prevention & control , Papillomavirus Vaccines/adverse effects , Child , Female , Humans , Injections, Intramuscular , Lymph Nodes/drug effects , Lymphadenopathy/pathology , Male , Papillomavirus Vaccines/administration & dosage , Vaccination
4.
BMJ Case Rep ; 12(11)2019 Nov 21.
Article in English | MEDLINE | ID: mdl-31753827

ABSTRACT

A 15-year-old boy with a medical background of obesity, familial hyperlipidemia and acute recurrent pancreatitis, presented to emergency department reporting a 3-day course of periumbilical abdominal pain and nausea. Pain was noticed on epigastric palpation. Laboratory evaluation revealed leucocytosis, neutrophilia and pancreatic enzymes elevation more than three times the upper limit of normal. An acute recurrence of pancreatitis was diagnosed, was admitted to the hospital, being discharged after 5 days. Four days after, he was readmitted because of symptoms recurrence. Elevation of transaminases, gamma-glutamyltransferase (GGT) and direct bilirubin were noticed. Pancreatic enzymes still elevated but lower than in the previous episode. An endoscopic ultrasound revealed a Wirsung with a cephalic stricture and diffuse structural abnormalities suggestive of chronic pancreatitis. The patients was submitted to endotherapy with several sessions of endoscopic retrograde cholangiopancreatography including stenting and pancreatoscopy with marked clinical and imaging improvement. A genetic variant was identified.


Subject(s)
Pancreatitis, Chronic/diagnosis , Pancreatitis, Chronic/therapy , Abdominal Pain/etiology , Adolescent , Calculi/diagnostic imaging , Calculi/therapy , Cholangiopancreatography, Endoscopic Retrograde , Constriction, Pathologic/therapy , Diagnosis, Differential , Endosonography , Humans , Male , Nausea/etiology , Pancreatic Ducts/diagnostic imaging , Pancreatic Ducts/pathology , Recurrence , Stents
5.
J Pediatr (Rio J) ; 90(1): 78-84, 2014.
Article in English | MEDLINE | ID: mdl-24156836

ABSTRACT

OBJECTIVE: To validate the Portuguese version of the Children's Sleep Habits Questionnaire (CSHQ-PT) and compare it to the versions from other countries. METHODS: The questionnaire was previously adapted to the Portuguese language according to international guidelines. 500 questionnaires were delivered to the parents of a Portuguese community sample of children aged 2 to 10 years old. 370 (74%) valid questionnaires were obtained, 55 children met exclusion criteria and 315 entered in the validation study. RESULTS: The CSHQ-PT internal consistency (Cronbach's α) was 0.78 for the total scale and ranged from 0.44 to 0.74 for subscales. The test-retest reliability for subscales (Pearson's correlations, n=58) ranged from 0.59 to 0.85. Our data did not adjust to the original 8 domains structure in Confirmatory Factor Analysis but the Exploratory Factor Analysis extracted 5 factors that have correspondence to CSHQ subscales. CONCLUSION: The CSHQ-PT evidenced psychometric properties that are comparable to the versions from other countries and adequate for the screening of sleep disturbances in children from 2 to 10 years old.


Subject(s)
Cross-Cultural Comparison , Sleep Wake Disorders/diagnosis , Sleep , Surveys and Questionnaires/standards , Child , Child, Preschool , Factor Analysis, Statistical , Female , Humans , Language , Male , Parents , Portugal , Psychometrics , Reproducibility of Results , Translating
6.
Microb Drug Resist ; 9(1): 99-108, 2003.
Article in English | MEDLINE | ID: mdl-12705689

ABSTRACT

Between 1997 and 2000 nasopharyngeal specimens were obtained from 466 children < or = 12 years old attending the Pediatric Emergency Department at S. Francisco Xavier Hospital, Lisbon, to evaluate risk factors for nasopharyngeal carriage of Haemophilus influenzae and Streptococcus pneumoniae and to characterize their phenotype and antimicrobial susceptibility. The attending pediatrician completed written questionnaires about the children's demographic and clinical histories. Over half the children (52.8%) carried H. influenzae and/or S. pneumoniae. Forty-one percent of these children had H. influenzae, 22.8% had S. pneumoniae and 36.2% had both. Risk factors identified for carriage of respiratory pathogens were: age below 3 years (p < 0.05), black race (p < 0.01), attending a daycare center (p < 0.05), and having a lower respiratory infection (p < 0.05). Asthmatic children were less likely to be carriers (p = 0.004). About two-thirds of H. influenzae isolates were susceptible to all antibiotics tested, 7.9% were beta-lactamase producers, 16.4% were nonsusceptible to trimethoprim, and 6.9% were intermediately resistant to clarithromycin. Over half (57.1%) of S. pneumoniae isolates were susceptible to all antibiotics tested, 21.1% were multiresistant, 23.3% were nonsusceptible to penicillin, and about 20% were resistant to macrolides. Low-level resistance to third-generation cephalosporins was detected in 2.3%. The data reflect the controversy surrounding risk factors of nasopharyngeal colonization. These may have significant implications on clinical practice and on antimicrobial strategies to prevent the appearance of further resistant strains. Our findings highlight the importance to investigate the relationship between asthma and carriage.


Subject(s)
Anti-Bacterial Agents/pharmacology , Carrier State/microbiology , Haemophilus influenzae/drug effects , Nasopharynx/microbiology , Streptococcus pneumoniae/drug effects , Carrier State/epidemiology , Child , Child, Preschool , Drug Resistance, Bacterial , Female , Haemophilus influenzae/classification , Haemophilus influenzae/isolation & purification , Humans , Infant , Infant, Newborn , Male , Phenotype , Portugal/epidemiology , Risk Factors , Streptococcus pneumoniae/classification , Streptococcus pneumoniae/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...